This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Edwards Lifescience EU probe dropped after company withdraws 'copycat' policy

( February 16, 2026, 10:46 GMT | Official Statement) -- MLex Summary: Edwards Lifesciences' EU probe has been closed after the European Commission said the US company had withdrawn a so-called anti-copycatting policy that "may have limited physicians' freedom to participate in clinical trials" with a rival maker of heart-valve devices. The company faced an antitrust investigation but the EU regulator said its concerns had been addressed and "further action is no longer considered a priority at EU level."The statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections